###begin article-title 0
###xml 0 39 0 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Catechol-O-Methyltransferase (COMT) Val</italic>
###xml 39 47 39 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 104 112 <span type="species:ncbi:9606">children</span>
Catechol-O-Methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 45 74 45 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">catechol-O-methyltransferase </italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 314 322 <span type="species:ncbi:9606">children</span>
###xml 562 570 <span type="species:ncbi:9606">children</span>
An association has been observed between the catechol-O-methyltransferase (COMT) gene, the predominant means of catecholamine catabolism within the prefrontal cortex (PFC), and neuropsychological task performance in healthy and schizophrenic adults. Since several of the cognitive functions typically deficient in children with Attention Deficit Hyperactivity Disorder (ADHD) are mediated by prefrontal dopamine (DA) mechanisms, we investigated the relationship between a functional polymorphism of the COMT gene and neuropsychological task performance in these children.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 7 15 7 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 70 78 <span type="species:ncbi:9606">children</span>
The Val108/158 Met polymorphism of the COMT gene was genotyped in 118 children with ADHD (DSM-IV). The Wisconsin Card Sorting Test (WCST), Tower of London (TOL), and Self-Ordered Pointing Task (SOPT) were employed to evaluate executive functions. Neuropsychological task performance was compared across genotype groups using analysis of variance.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val/Val</italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val/Met </italic>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met/Met </italic>
###xml 217 222 217 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,97 </sub>
###xml 267 272 267 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,99 </sub>
###xml 315 321 315 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,108 </sub>
###xml 5 13 <span type="species:ncbi:9606">children</span>
ADHD children with the Val/Val, Val/Met and Met/Met genotypes were similar with regard to demographic and clinical characteristics. No genotype effects were observed for WCST standardized perseverative error scores [F2,97 = 0.67; p > 0.05], TOL standardized scores [F2,99 = 0.97; p > 0.05], and SOPT error scores [F2,108 = 0.62; p > 0.05].
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 73 81 73 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 226 234 <span type="species:ncbi:9606">children</span>
Contrary to the observed association between WCST performance and the Val108/158 Met polymorphism of the COMT gene in both healthy and schizophrenic adults, this polymorphism does not appear to modulate executive functions in children with ADHD.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 647 654 647 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC6A3 </italic>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRD4 </italic>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 193 201 <span type="species:ncbi:9606">children</span>
Attention Deficit Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder characterized by symptoms of inattention, impulsivity and motor hyperactivity afflicting 6-8% of school-aged children in North America [1,2]. Although ADHD is a disorder with complex and heterogeneous etiology, genetic factors appear to play a significant role in predisposing and perpetuating the development of the disorder as evidenced by twin [3,4], family [5-7], and adoption studies [8]. Association studies have implicated several susceptibility loci including a 40-base pair (bp) allele of the Variable Number of Tandem Repeats (VNTR) polymorphism of the SLC6A3 gene [9] and a 48-bp repeat polymorphism of the DRD4 gene [10]. Attempts to replicate these findings have met with modest success possibly owing to the clinical heterogeneity characteristic of the disorder [11]. One method that may act to augment the strength of these associations would be to identify endophenotypic intermediates conferring risk for the development of ADHD rather than attempting to identify direct linkages between genetic variations and the behavioural manifestation of the disorder.
###end p 11
###begin p 12
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 578 581 <span type="species:ncbi:10116">rat</span>
###xml 679 687 <span type="species:ncbi:9606">children</span>
Theories of dysregulated dopamine (DA) pathways in ADHD have been supported by the efficacy of dopamine agonists in reducing the core symptoms of the disorder [12]. The mesocortical DA pathway appears to be integral to prefrontal cortex (PFC)-mediated cognitive functioning, specifically working memory [13], through the enhancement of task-related neural activity via D1 receptor activation [14]. Both PET [15] and SPECT [16] imaging studies support a neuromodulatory role for DA in the PFC during tasks of executive function. In addition, administration of DA agonists to the rat PFC acts to enhance working memory in these animals [17]. Consistent with this line of thinking, children with ADHD show deficits in performance of tasks of executive function [summarized in a meta-analysis by Sergeant et al. (2002)] [18] and significant improvement of performance under methylphenidate [19,20]. These findings have prompted the hypothesis that the overt symptoms of ADHD are the manifestation of an underlying deficiency in a range of PFC-mediated cognitive domains, including working memory, planning, and set shifting, collectively regarded as executive function [21-23].
###end p 12
###begin p 13
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC6A3 </italic>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRD4 </italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 247 276 247 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">catechol-O-methyltransferase </italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT</italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT</italic>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met</italic>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 545 553 545 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 553 556 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met</italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val </italic>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1153 1158 1153 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1220 1225 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1240 1245 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1390 1393 1390 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 1393 1401 1393 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 1401 1405 1401 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 1644 1647 1644 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 1647 1655 1647 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 1655 1659 1655 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 1749 1751 1749 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1752 1754 1752 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1844 1846 1844 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1898 1903 1898 1903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1938 1940 1938 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1941 1943 1941 1943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 2001 2006 2001 2006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 2068 2070 2068 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2200 2201 2200 2201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 2202 2204 2202 2204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2205 2207 2205 2207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1082 1086 <span type="species:ncbi:10116">rats</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
The hypothesized role of a dysfunctional mesocortical dopaminergic pathway in the development of symptoms of ADHD has encouraged the investigation of candidate genes involved in this pathway including SLC6A3 [9], DRD4 [10] and, more recently, the catechol-O-methyltransferase (COMT) gene [24]. The COMT, encoded by a gene located on chromosome 22q11, catalyzes the degradation of catecholamines, most importantly DA [25]. A functional polymorphism of this gene, involving a substitution of Valine (Val) for Methionine (Met) at codon 108/158 (Val108/158 Met), results in a 4-fold variation in enzyme activity, with individuals homozygous for either the Val or Met allele exhibiting either reduced or preserved levels of DA respectively [26]. Although the dopamine transporter (DAT) is the predominant means of DA termination in most dopaminergic neurons [27], considerable evidence exists to suggest that the DAT may play a reduced role within the PFC [28-32], where other clearance mechanisms may be implicated. Comparison of DA metabolite levels within discrete brain loci in both rats [33] and monkeys [34], as well as the measurement of DA levels in COMT knock-out mice [35], suggest an important functional role for COMT in the PFC. If COMT is indeed inextricably linked to DA metabolism within the PFC, it is reasonable to assume that variations in enzyme activity, as dictated by the Val108/158 Met polymorphism, may modulate the performance of tasks of executive functioning in healthy individuals, as well as individuals with reduced PFC basal dopamine levels. In support of this assumption, associations have been reported between the Val108/158 Met polymorphism and performance on the Wisconsin Card Sorting Test (WCST) in healthy adults [36,37]. In adults with Schizophrenia, a disorder characterized by dopaminergic hypofrontality [38], associations have also been observed between the COMT polymorphism and WCST performance [39-41]. Although one study reported an association between the COMT polymorphism and ADHD using a haplotype relative risk design [24], this study failed to investigate any indices of executive function and several other studies failed to replicate this finding [3,42-44].
###end p 13
###begin p 14
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 101 109 101 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val </italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 780 784 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1225 1227 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 410 418 <span type="species:ncbi:9606">children</span>
###xml 556 564 <span type="species:ncbi:9606">children</span>
###xml 978 986 <span type="species:ncbi:9606">children</span>
###xml 1201 1209 <span type="species:ncbi:9606">children</span>
###xml 1351 1359 <span type="species:ncbi:9606">children</span>
Given the putative role of COMT in DA metabolism within the PFC [33-35], we hypothesized that the Val108/158 Met polymorphism of the COMT gene will be associated with alterations in performance on tasks of executive function, a behavioural index of PFC integrity and function [45]. Since dysfunctional DA neurotransmission [46] and deficient neuropsychological task performance [18] are both characteristic of children with ADHD, we further hypothesized that this association would be evident within this particular clinical population. Specifically, ADHD children expressing the high enzymatic activity Val allele (H), resulting in reduced PFC DA neurotransmission [26], will show more pronounced deficits in neuropsychological task performance than their low enzymatic activity Met allele (L) counterparts. In order to test this hypothesis, we used three measures of executive function: the WCST [47], a measure of set-shifting ability capable of differentiating between ADHD children and controls [18] and associated with the COMT polymorphism in normal [36,37] and schizophrenic adults [39-41]; the Tower of London (TOL) [48], a measure of planning ability, which consistently differentiates ADHD children from controls [18], and the Self-Ordered Pointing Task (SOPT) [49], a measure of working memory also capable of differentiating between ADHD children and controls [18].
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 4 12 <span type="species:ncbi:9606">children</span>
###xml 84 92 <span type="species:ncbi:9606">children</span>
118 children were recruited from the Disruptive Behaviour Disorders Program and the children outpatient clinic at the Douglas Hospital. They were referred to these specialized care facilities by school principals, community social workers, and paediatricians.
###end p 17
###begin p 18
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 28 36 <span type="species:ncbi:9606">children</span>
###xml 319 324 <span type="species:ncbi:9606">child</span>
###xml 457 462 <span type="species:ncbi:9606">child</span>
###xml 540 545 <span type="species:ncbi:9606">Child</span>
###xml 785 793 <span type="species:ncbi:9606">children</span>
###xml 1095 1100 <span type="species:ncbi:9606">child</span>
Inclusion criteria required children to be between the ages of 6 and 12 years of age, meeting DSM-IV diagnosis criteria for ADHD [50]. Diagnosis of ADHD was based on a structured clinical interview of parents using the DISC-IV (parental report) [51], school reports, teacher interviews, and clinical observation of the child. In the majority of cases, mothers were the primary informants for the collection of clinical information. Written reports from the child's school were also available in the majority of cases. Parents completed the Child Behavioural Checklist (CBCL) [52], a scale that assesses a variety of behavioural domains, and the Conners' Global Index for parents (CGI-P) [53]. Teachers also completed the Conners' Global Index (CGI-T) [54]. Assessments were made while children were free of medication. Exclusion criteria included a history of mental retardation, with an IQ less than or equal to 70 as measured by the WISC-III [55], and history of Tourette Syndrome, pervasive developmental disorder, psychosis or any medical condition or impairment that may interfere with the child's ability to complete the study.
###end p 18
###begin title 19
Neurocognitive assessment
###end title 19
###begin p 20
###xml 135 143 <span type="species:ncbi:9606">children</span>
###xml 179 187 <span type="species:ncbi:9606">children</span>
###xml 257 265 <span type="species:ncbi:9606">Children</span>
###xml 576 584 <span type="species:ncbi:9606">Children</span>
A comprehensive neuropsychological test battery assessing different aspects of the central executive functions was administered to all children by trained research personnel. All children were assessed subsequent to a one-week medication "wash-out" period. Children were permitted to take breaks upon request and, in some cases, testing was carried out over two sessions. On average, the testing procedure lasted 1.5 hours. The research protocol was approved by the Research Ethics Board of the Douglas Hospital. Parents were explained the study and provided written consent. Children were also explained the study and gave their assent to participate as well.
###end p 20
###begin p 21
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1246 1248 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1867 1869 1867 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 345 353 <span type="species:ncbi:9606">children</span>
###xml 499 504 <span type="species:ncbi:9606">child</span>
###xml 647 652 <span type="species:ncbi:9606">child</span>
###xml 1413 1418 <span type="species:ncbi:9606">child</span>
###xml 1424 1429 <span type="species:ncbi:9606">child</span>
###xml 1519 1524 <span type="species:ncbi:9606">child</span>
###xml 1615 1620 <span type="species:ncbi:9606">child</span>
###xml 1825 1833 <span type="species:ncbi:9606">children</span>
Tests were selected according to their ability to tap into various performance domains of executive function. We restricted the number of tests in each domain in order to balance comprehensiveness with the co-operation of patients. Abstraction and concept formation were evaluated by means of the WCST (perseverative errors) [47]. In this task, children are required to sort cards according to three different criteria (colour, number, or shape of signs presented on cards). Feedback on whether the child achieved a correct or incorrect match is given after each trial. The matching criterion changes after ten consecutive correct matches and the child has to identify the new matching criterion using the feedback (correct/incorrect) provided to them. Evidence of the reliability and validity of the WCST with various normal and clinical populations has been reported in several studies [18]. Planning capacity was evaluated using the TOL [48]. This test is used to assess planning and problem solving aspects of executive functioning. The validity and reliability of the TOL has been reported in numerous studies [18]. Standardized administration and scoring procedures as well as normative data have been developed for paediatric populations [56]. Visual Working Memory was evaluated using the abstract version of the SOPT [49]. In this task, series of matrices of 6, 8, 10, and 12 images are presented to the child. The child is asked to select, by pointing, one different image on each page. Errors occur when the child points to images previously selected on the preceding pages. Each set is presented to the child three times. Successful performance on this task involves working memory as well as planning and monitoring skills. Shue & Douglas (1992) have reported significant differences in performance between ADHD children and normal controls on the SOPT [57].
###end p 21
###begin title 22
Molecular genetics
###end title 22
###begin p 23
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 7 15 7 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 671 679 <span type="species:ncbi:9606">Children</span>
The Val108/158 Met polymorphism of the COMT gene was genotyped using a PCR based method as previously described [26]. The PCR was performed in a 25 mul total reaction volume containing 1X PCR buffer, 200 uM dNTPs, 200 ng of primers (5'-GCGATGGTGGCACTCCAAGC; 5'-TTGGAGAGGCTGAGGCTGAC), 1 unit of Taq DNA polymerase, and 100 ng of genomic DNA. PCR products were electrophoresed on agarose-TAE gel along with 1 kb ad 100 bp DNA ladders, visualized under UV-light and coded according to the length of the PCR product. Genotypes were called by two independent and experienced technicians who were blind to all clinical data. No disconcordance in any of the readings was noted. Children were stratified according to genotype only after all neuropsychological task data was collected.
###end p 23
###begin title 24
Statistical analyses
###end title 24
###begin p 25
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 7 15 7 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val </italic>
The Val108/158 Met polymorphism consists of both the low-activity Met (L) and high-activity Val (H) alleles. Subjects were stratified into three groups: two homozygous genotype groups (LL, HH) and one heterozygous genotype group (HL).
###end p 25
###begin p 26
A one-way analysis of variance (ANOVA) where genotype (LL, HL, HH) was the independent variable and neuropsychological task performance (standardized WCST perseverative error score, standardized TOL total item score) was the dependent variable was performed. For the SOPT, no normalized scores are available and testing procedures involve several levels of difficulty (4). We therefore used a two-way, repeated measure, mixed design analysis of covariance (ANCOVA), where genotype and level of task difficulty were the between and within subjects independent variables, respectively, neuropsychological task performance (SOPT raw error score) was the dependent variable, and age was the covariate. As the TOL also involves multiple levels of task difficulty (12), we repeated the analysis for this test using the same statistical approach as that applied to the SOPT. A one-way ANCOVA, where genotype was the independent variable and age was the covariate, was performed on all other non-standardized measures of neuropsychological task performance (WCST number of categories completed, WCST number of trials to first category, TOL number of problems solved).
###end p 26
###begin p 27
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
An investigation of linkage and within-family association between quantitative phenotypes (standardized WCST perseverative error score, standardized TOL error score, and SOPT error score) was conducted utilizing the Quantitative Trait Disequilibrium Test (QTDT) statistical software package [58].
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 962 964 960 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1289 1294 1287 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1300 1302 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 59 67 <span type="species:ncbi:9606">children</span>
Table 1 shows clinical and demographic information for the children stratified according to genotype [n = 23 for LL (19.5%), n = 66 for HL (56.0%) and n = 29 for HH (24.5%)]. The three groups were similar with regard to age, average household income, severity of behavioural problems as assessed by the CBCL, and mean number of inattention items, mean number of hyperactivity items and distribution of ADHD subtypes according to the DISC-IV. No significant differences existed between the groups in IQ as measured by the WISC-III. Our sample was characterized by a high prevalence of comorbid disorders, particularly oppositional defiant disorder and conduct disorder. The frequency of these disorders was equally distributed between the genotype groups. The proportion of subjects who had never received medication for ADHD within each genotype group was also remarkably similar. Although a significant effect of gender was observed between genotype groups (chi2 = 7.39; df = 2, p = 0.02), this result was treated as a type I error (false positive) due to the absence of female subjects with the HH genotype and given the relative lack of female representation across all genotype groups. However, given the previously observed association between gender and several polymorphisms at the COMT loci [59], increasing the sample size to achieve a more comparable gender representation and distribution would be a valuable revision to the present design.
###end p 29
###begin p 30
###xml 44 52 <span type="species:ncbi:9606">children</span>
Demographic and clinical characteristics of children with ADHD separated according to COMT genotype
###end p 30
###begin p 31
###xml 7 12 <span type="species:ncbi:9606">Child</span>
###xml 79 87 <span type="species:ncbi:9606">Children</span>
CBCL = Child Behavioral Checklist. DISC-IV = Diagnostic Interview Schedule for Children fourth edition. ODD = Opposition Defiant Disorder, CD = Conduct Disorder. ADHD Subtypes: I = Inattentive, H = Hyperactive, C = Combined. Values are mean (SD).
###end p 31
###begin p 32
###xml 72 74 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 245 249 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val </italic>
###xml 369 371 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 464 468 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 588 590 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 793 798 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 274 282 <span type="species:ncbi:9606">children</span>
###xml 493 501 <span type="species:ncbi:9606">children</span>
The genotype distribution conformed to a Hardy-Weinberg equilibrium (chi2 = 0.42; df = 2, p = 0.81). 156 parents participated in the study and gave blood samples. Among these parents, 76 were heterozygous (M = 43 and F = 33) and transmitted the Val allele to their affected children in 28 occurrences, whereas this same allele was not transmitted in 29 occurrences [chi2 = 0.02; df = 1, p > 0.05 (transmission disequilibrium)]. Conversely, parents transmitted the Met allele to their affected children in 29 occurrences, whereas this same allele was not transmitted in 28 occurrences [chi2 = 0.02; df = 1, p > 0.05 (transmission disequilibrium)]. In addition, results from the QTDT revealed no evidence of linkage or within-family association between the three quantitative phenotypes and the COMT gene.
###end p 32
###begin p 33
###xml 172 177 172 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,97 </sub>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 245 250 245 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,99 </sub>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 400 406 400 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,108 </sub>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 457 463 457 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,107 </sub>
###xml 520 526 520 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,108 </sub>
###xml 618 624 618 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6,327 </sub>
###xml 665 673 665 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">11,1199 </sub>
###xml 730 738 730 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink">11,1210 </sub>
###xml 870 875 870 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,96 </sub>
###xml 936 941 936 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,96 </sub>
###xml 995 1001 995 1001 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,112 </sub>
###xml 1225 1230 1225 1230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,98 </sub>
###xml 1287 1292 1287 1292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,97 </sub>
###xml 1353 1358 1353 1358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,97 </sub>
###xml 1414 1420 1414 1420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,100 </sub>
###xml 1461 1467 1461 1467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,108 </sub>
###xml 1520 1526 1520 1526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,109 </sub>
###xml 1577 1582 1577 1582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,113</sub>
###xml 1628 1634 1628 1634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,109 </sub>
A one-way ANOVA performed on these data revealed no significant difference between the LL, HL, and HH genotypes according to WCST standardized perseverative error scores [F2,97 = 0.66, p > 0.05](Table 2) and TOL standardized total item scores [F2,99 = 0.97, p > 0.05](Table 2). A repeated-measure, mixed design ANCOVA performed on these data revealed no effect of genotype on SOPT raw error scores [F2,108 = 0.62, p > 0.05] (Table 2), TOL raw item scores [F2,107 = 0.35, p > 0.05], and TOL time to complete each trial [F2,108 = 0.04, p > 0.05]. No genotype by task interaction was observed for SOPT raw error scores [F6,327 = 0.39, p > 0.05], TOL raw item scores [F11,1199 = 1.63, p > 0.05], and TOL time to complete each trial [F11,1210 = 1.65, p > 0.05]. A one-way ANCOVA performed on these data revealed no effect of genotype on WCST number of categories completed [F2,96 = 1.94, p > 0.05], WCST number of trials to first category [F2,96 = 1.04, p > 0.05] and TOL number of problems solved [F2,112 = 1.04, p > 0.05]. No genotype effects were observed when the HL and HH genotype groups were combined into one category and contrasted with the LL genotype (recessive model) on WCST standardized perseverative error scores [F1,98 = 1.11, p > 0.05], WCST number of categories completed [F1,97 = 0.01, p > 0.05], WCST number of trials to first category [F1,97 = 0.36, p > 0.05], TOL standardized total item scores [F1,100 = 0.42, p > 0.05], TOL raw item scores [F1,108 = 0.22, p > 0.05], TOL time to complete each trial [F1,109 = 0.07, p > 0.05], TOL number of problems solved [F1,113= 1.33, p > 0.05] and SOPT raw error scores [F1,109 = 0.85, p > 0.05].
###end p 33
###begin p 34
###xml 39 47 <span type="species:ncbi:9606">children</span>
Neuropsychological task performance in children with ADHD
###end p 34
###begin p 35
WCST = Wisconsin Card Sorting Test standardized perseverative error score (LL: n = 21, HL: n = 56, HH: n = 23). TOL = Tower of London standardized score (LL: n = 20, HL: n = 55, HH: n = 27). SOPT = Self Ordered Pointing Task error score (LL: n = 23, HL: n = 63, HH: n = 26). ES = Effect size for LL vs. HH. Values are mean (SD).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 474 482 474 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT Val</italic>
###xml 482 489 482 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158</sup>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 803 806 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 806 814 806 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1170 1178 1170 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT Val</italic>
###xml 1178 1185 1178 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158</sup>
###xml 1185 1189 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 948 956 <span type="species:ncbi:9606">children</span>
###xml 1245 1253 <span type="species:ncbi:9606">children</span>
Previous studies have identified an association between the COMT polymorphism and a variety of indices reflecting executive control both in healthy [36,37] and schizophrenic adults [39-41]. The COMT appears to be important to the regulation of dopamine metabolism within the PFC [33-35]. Since the PFC and dopamine pathways have been hypothesized to play an important role in the pathogenesis of ADHD [9-11,60,61]), we conducted this study in an attempt to test whether the COMT Val108/158Met polymorphism, which is known to be associated with a significant change in the catabolic capacity of this enzyme, modulates the risk for ADHD or various indices of executive control. Contrary to our expectations and findings in both healthy [36,37] and schizophrenic adults [39-41], an association between the Val108/158 Met functional polymorphism of the COMT gene and neuropsychological task performance reflecting executive control was not observed in children with ADHD. This result is consistent with the findings of a recent case-control study conducted by Mills et al. (2004), which, to our knowledge, is the only other study to investigate the relationship between the COMT Val108/158Met polymorphism and neuropsychological task performance in children with ADHD [62]. However, this study did not include the WCST, the measure responsible for producing the most consistent results in the previous literature. In addition, we did not identify a biased transmission of either of the two alleles from parents to affected offspring.
###end p 37
###begin p 38
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT Val</italic>
###xml 50 57 50 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158</sup>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 775 780 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1290 1295 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 1449 1450 1449 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1451 1453 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1454 1456 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1457 1459 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1474 1478 1474 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT</italic>
###xml 122 130 <span type="species:ncbi:9606">children</span>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 455 459 <span type="species:ncbi:10116">rats</span>
###xml 472 478 <span type="species:ncbi:9606">humans</span>
###xml 708 711 <span type="species:ncbi:10116">rat</span>
###xml 925 933 <span type="species:ncbi:9606">children</span>
###xml 1307 1315 <span type="species:ncbi:9606">children</span>
The absence of an association between the COMT Val108/158Met polymorphism and behavioral indices of executive function in children with ADHD may be explained by the young age of the population of patients included in the present study. Indeed it is possible that, due to age-related changes in the functional importance of the COMT within the prefrontal cortex, this association is observable only in adults. This possibility is supported by data in both rats [63-65] and humans [66,67] suggesting that monoamine content and metabolism decrease with age. This age-related decrease may render functions dependent on monoamine content more prone to be dysfunctional at an older age. In addition, evidence from rat studies has indicated a positive correlation between aging and COMT activity [68-70]. This observation may suggest that the implication of the COMT in the catabolism of dopamine is developmentally regulated, with children relying less on this catabolic pathway than adults. Conversely, it has been reported that DAT density is inversely correlated with age [71]. Taken together, the presence of an inverse and direct correlation between age and DAT density on the one hand and COMT activity on the other hand, may suggest that dopamine metabolism relies more on the DAT than on COMT activity in children compared to adults. This hypothesis is compatible with the fact that several studies have identified an association between the DAT [9,60,72-74], but not the COMT, gene and ADHD.
###end p 38
###begin p 39
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
It is also possible that the negative result observed in the present study is due to a type II error (false negative) secondary to the lack of power of our sample to detect an association. However, using results from the WCST, the variable for which relevant genetic data already exists, we conducted a power analysis and determined that our sample size has sufficient power (80% at alpha = .05) to detect a mean difference of 11.2 on this measure. Furthermore, it is possible that some of the tests used in our assessment are mediated by the PFC but insensitive to PFC DA levels [75].
###end p 39
###begin p 40
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
An additional limitation of the present study is that some genotype groups included few subjects. Increasing the sample size to achieve larger genotype groups would be necessary to reach firmer conclusions. This is particularly true for female subjects who were significantly underrepresented in the study (as is common to most clinical studies of ADHD). In order to generalize these negative results to females, a more comparable gender representation is required, particularly in view of some previous research indicating that the allelic distribution of the COMT may be gender dependent [59].
###end p 40
###begin title 41
Conclusions
###end title 41
###begin p 42
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val</italic>
###xml 54 62 54 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">108/158 </sup>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 187 195 <span type="species:ncbi:9606">children</span>
This study does not support the involvement of the Val108/158 Met polymorphism of the COMT gene in increasing the risk for ADHD or in modulating several indices of executive functions in children with ADHD. This result is contrary to previous findings in both healthy and schizophrenic adults and may be related to developmental specificities.
###end p 42
###begin title 43
Competing interests
###end title 43
###begin p 44
The author(s) declare that they have no competing interests.
###end p 44
###begin title 45
Authors' contributions
###end title 45
###begin p 46
ET performed the data analysis and drafted the manuscript. NG was involved in the conception of the study and provided clinical support. LBA provided clinical support and aided in data collection. PL provided clinical support. VM aided in neuropsychological testing and data collection. RD and ATZ performed the genotyping for the study and aided in data management. MTS coordinated the clinical aspects of the study and was involved in data management. CB provided clinical support. RJ was responsible for the conception of the study, drafting of the manuscript, and supervision of the research project.
###end p 46
###begin title 47
Pre-publication history
###end title 47
###begin p 48
The pre-publication history for this paper can be accessed here:
###end p 48
###begin p 49

###end p 49
###begin title 50
Acknowledgements
###end title 50
###begin p 51
This work was supported in part by grants from the Fonds de la Recherche en Sante du Quebec, Reseau de Sante Mentale du Quebec, and the Canadian Institutes of Health Research to RJ and ET. We thank Johanne Bellingham, Anna Polotskaia and Nicole Pawliuk for technical assistance.
###end p 51
###begin article-title 52
###xml 8 13 <span type="species:ncbi:9606">Child</span>
Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity
###end article-title 52
###begin article-title 53
Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder
###end article-title 53
###begin article-title 54
Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study
###end article-title 54
###begin article-title 55
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples
###end article-title 55
###begin article-title 56
###xml 67 75 <span type="species:ncbi:9606">children</span>
An exploratory study of ADHD among second-degree relatives of ADHD children
###end article-title 56
###begin article-title 57
###xml 12 20 <span type="species:ncbi:9606">children</span>
Families of children with attention deficit hyperactivity disorder: a review
###end article-title 57
###begin article-title 58
An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality
###end article-title 58
###begin article-title 59
Association of attention-deficit disorder and the dopamine transporter gene
###end article-title 59
###begin article-title 60
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
###end article-title 60
###begin article-title 61
Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD
###end article-title 61
###begin article-title 62
###xml 80 88 <span type="species:ncbi:9606">Children</span>
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices
###end article-title 62
###begin article-title 63
The cortical dopamine system: role in memory and cognition
###end article-title 63
###begin article-title 64
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
###end article-title 64
###begin article-title 65
Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study
###end article-title 65
###begin article-title 66
The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia
###end article-title 66
###begin article-title 67
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex
###end article-title 67
###begin article-title 68
How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?
###end article-title 68
###begin article-title 69
###xml 93 101 <span type="species:ncbi:9606">children</span>
Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom
###end article-title 69
###begin article-title 70
Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder
###end article-title 70
###begin article-title 71
Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD
###end article-title 71
###begin article-title 72
Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research
###end article-title 72
###begin article-title 73
###xml 22 30 <span type="species:ncbi:9606">children</span>
Cognitive deficits in children with attention-deficit disorder with hyperactivity
###end article-title 73
###begin article-title 74
Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype
###end article-title 74
###begin article-title 75
Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
###end article-title 76
###begin article-title 77
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
###end article-title 77
###begin article-title 78
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Cellular and subcellular localization of the dopamine transporter in rat cortex
###end article-title 78
###begin article-title 79
Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization
###end article-title 79
###begin article-title 80
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Dopamine transporter density in patients with attention deficit hyperactivity disorder
###end article-title 80
###begin article-title 81
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
###end article-title 81
###begin article-title 82
Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition
###end article-title 82
###begin article-title 83
###xml 70 73 <span type="species:ncbi:10116">rat</span>
3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model
###end article-title 83
###begin article-title 84
Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates
###end article-title 84
###begin article-title 85
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
###end article-title 85
###begin article-title 86
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition
###end article-title 86
###begin article-title 87
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
###end article-title 87
###begin article-title 88
Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia
###end article-title 88
###begin article-title 89
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
###end article-title 89
###begin article-title 90
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test
###end article-title 90
###begin article-title 91
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia
###end article-title 91
###begin article-title 92
Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study
###end article-title 92
###begin article-title 93
###xml 117 125 <span type="species:ncbi:9606">children</span>
Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children
###end article-title 93
###begin article-title 94
Dopaminergic system genes in ADHD: toward a biological hypothesis
###end article-title 94
###begin article-title 95
A connectionist approach to the prefrontal cortex
###end article-title 95
###begin article-title 96
Thyroid function and attention-deficit hyperactivity disorder
###end article-title 96
###begin article-title 97
A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigel-type card-sorting problem
###end article-title 97
###begin article-title 98
Specific impairments of planning
###end article-title 98
###begin article-title 99
###xml 78 81 <span type="species:ncbi:9606">man</span>
Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man
###end article-title 99
###begin article-title 100
###xml 68 76 <span type="species:ncbi:9606">children</span>
DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents
###end article-title 100
###begin article-title 101
Tower of London procedure: a standard method and developmental data
###end article-title 101
###begin article-title 102
Attention deficit hyperactivity disorder and the frontal lobe syndrome
###end article-title 102
###begin article-title 103
A general test of association for quantitative traits in nuclear families
###end article-title 103
###begin article-title 104
Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism
###end article-title 104
###begin article-title 105
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder
###end article-title 105
###begin article-title 106
Pathophysiology of attention-deficit hyperactivity disorder
###end article-title 106
###begin article-title 107
###xml 137 145 <span type="species:ncbi:9606">children</span>
No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study
###end article-title 107
###begin article-title 108
###xml 57 60 <span type="species:ncbi:10116">rat</span>
Characteristics of dopaminergic neurons in the aged male rat
###end article-title 108
###begin article-title 109
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Age-related alterations in catecholamine concentrations in discrete preoptic area and hypothalamic regions in the male rat
###end article-title 109
###begin article-title 110
###xml 41 45 <span type="species:ncbi:10116">rats</span>
Changes in endogenous monoamines in aged rats
###end article-title 110
###begin article-title 111
###xml 105 110 <span type="species:ncbi:9606">human</span>
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia
###end article-title 111
###begin article-title 112
###xml 109 114 <span type="species:ncbi:9606">human</span>
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis
###end article-title 112
###begin article-title 113
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Catechol-o-methyl transferase (COMT) in human and rat platelets
###end article-title 113
###begin article-title 114
###xml 81 85 <span type="species:ncbi:10116">rats</span>
Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats
###end article-title 114
###begin article-title 115
###xml 95 100 <span type="species:ncbi:9606">human</span>
Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex
###end article-title 115
###begin article-title 116
###xml 99 104 <span type="species:ncbi:9606">human</span>
Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia
###end article-title 116
###begin article-title 117
Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
###end article-title 117
###begin article-title 118
Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene
###end article-title 118
###begin article-title 119
Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms
###end article-title 119
###begin article-title 120
Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex
###end article-title 120

